Findakly Dawood, Wang Jue
Internal Medicine, Creighton University Arizona Health Education Alliance/Valleywise Health Medical Center, Phoenix, USA.
Genitourinary Oncology, Creighton University School of Medicine/University of Arizona Cancer Center at Dignity Health, Phoenix, USA.
Cureus. 2020 May 29;12(5):e8356. doi: 10.7759/cureus.8356.
Small cell carcinoma (SCC) of the prostate is rare in the spectrum of prostate tumors. Clinically, prostate SCC is more aggressive and has a poorer prognosis when compared to prostate acinar adenocarcinoma. Delay in diagnosis and misdiagnosis further worsens the outcome of this disease. Here we present a 68-year-old man whose prostate SCC was initially misdiagnosed with benign prostate hypertrophy (BPH) by his primary care physician (PCP) and urologist and small cell lung cancer by his first oncologist and pathologist. This case underscores the diagnostic conundrum of prostate SCC and the importance of exercising caution against the possibility of uncommon prostate cancer misdiagnosis in clinical practice.
前列腺小细胞癌（SCC）在前列腺肿瘤谱系中较为罕见。临床上，与前列腺腺泡腺癌相比，前列腺SCC侵袭性更强，预后更差。诊断延迟和误诊会进一步恶化该疾病的预后。在此，我们报告一名68岁男性，其前列腺SCC最初被初级保健医生（PCP）和泌尿科医生误诊为良性前列腺增生（BPH），并被首位肿瘤学家和病理学家误诊为小细胞肺癌。该病例凸显了前列腺SCC的诊断难题，以及在临床实践中对罕见前列腺癌误诊可能性保持警惕的重要性。
